CD

Chetan Dattatray Pachpor

Active Director Designated Partner DIN 11289391
DIN 11289391 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chetan Dattatray Pachpor

Data last updated:

Chetan Dattatray Pachpor is a Designated Partner at Scp Pharma Consultancy Llp (since 2025).

DIN 11289391
Primary Designation Designated Partner
First Appointment 09 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Sep 20252025Active

Board colleagues of Chetan Dattatray Pachpor

NameDINCompanyDesignation
Partha Chakraborty11289389Scp Pharma Consultancy LlpDesignated Partner
Sreenivas Satya Venkata Rompecherla11289390Scp Pharma Consultancy LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Scp Pharma Consultancy Llp
Premium access

Shareholding and investment profile for Chetan Dattatray Pachpor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chetan Dattatray Pachpor

Chetan Dattatray Pachpor currently holds 1 directorship: Scp Pharma Consultancy Llp (Designated Partner, since 09 Sep 2025).

Chetan Dattatray Pachpor was first appointed on 09 Sep 2025 as Designated Partner at Scp Pharma Consultancy Llp.

The current boards of Chetan Dattatray Pachpor's companies include Partha Chakraborty (Scp Pharma Consultancy Llp), Sreenivas Satya Venkata Rompecherla (Scp Pharma Consultancy Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available